- Home
- INM vs TTNP Comparison
INM vs TTNP Comparison
Compare INM & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- TTNP
- Stock Information
- Founded
- INM 1981
- TTNP 1991
- Country
- INM Canada
- TTNP United States
- Employees
- INM N/A
- TTNP N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INM Health Care
- TTNP Health Care
- Exchange
- INM Nasdaq
- TTNP Nasdaq
- Market Cap
- INM 3.2M
- TTNP 3.4M
- IPO Year
- INM N/A
- TTNP 1996
- Fundamental
- Price
- INM $2.95
- TTNP $4.67
- Analyst Decision
- INM
- TTNP
- Analyst Count
- INM 0
- TTNP 0
- Target Price
- INM N/A
- TTNP N/A
- AVG Volume (30 Days)
- INM 214.0K
- TTNP 42.9K
- Earning Date
- INM 05-27-2025
- TTNP 05-27-2025
- Dividend Yield
- INM N/A
- TTNP N/A
- EPS Growth
- INM N/A
- TTNP N/A
- EPS
- INM N/A
- TTNP N/A
- Revenue
- INM $4,920,990.00
- TTNP N/A
- Revenue This Year
- INM N/A
- TTNP N/A
- Revenue Next Year
- INM N/A
- TTNP N/A
- P/E Ratio
- INM N/A
- TTNP N/A
- Revenue Growth
- INM N/A
- TTNP N/A
- 52 Week Low
- INM $1.72
- TTNP $3.03
- 52 Week High
- INM $15.70
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- INM 53.78
- TTNP 57.83
- Support Level
- INM $2.08
- TTNP $4.52
- Resistance Level
- INM $4.00
- TTNP $5.10
- Average True Range (ATR)
- INM 0.35
- TTNP 0.50
- MACD
- INM 0.01
- TTNP 0.07
- Stochastic Oscillator
- INM 45.31
- TTNP 49.77
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.